A single centre, randomised controlled, open label study of rituximab as induction therapy in kidney transplantation
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Daclizumab; Rituximab
- Indications Renal transplant rejection
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- Acronyms Rituxicam2005
- 30 Aug 2009 Tolerability results have been reported at the 14th Congress of the European Society for Organ Transplantation.
- 18 Jun 2009 Results reported in the New England Journal of Medicine.
- 03 Jun 2009 Status changed from recruiting to discontinued; results reported at ATC 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History